期刊文献+

P16、CyclinD_1在胆管癌中的表达及意义 被引量:3

The Expressions and Significance of P16. Cyclin D_1 Proteins in Cholangiocarcinoma
下载PDF
导出
摘要 [目的]通过对P16、CyclinD1蛋白在胆管癌中表达的检测,探讨其与胆管癌临床病理特征、淋巴结转移的关系。[方法]采用SP免疫组化方法检测45例胆管癌及10例正常胆管石蜡标本中P16、CyclinD1蛋白的表达,分析其表达与临床病理的关系。[结果]正常胆管中CyclinD1蛋白无阳性表达CyclinD1在胆管癌中阳性表达为66.67%,两者比较有显著差异(P〈0.01).P16在正常胆管中均有表达(100%),胆管癌中表达率37.78%,下调明显(P〈0.05);P16与胆管癌临床分期相关(Ⅱ-Ⅲ与Ⅳ期比较P=0.015);CyclinD1与胆管癌临床病理分期相关(Ⅱ-Ⅲ与Ⅳ期比较P=0.002);P16与CyclinD1蛋白表达呈负相关(r=-0.374,P〈0.05)。[结论]P16基因的失活及其表达缺失和CyclinD1基因的激活及其过表达参与调节胆管癌的发生发展,且CyclinD1可以作为胆管癌组织分化的潜在生化标记,P16与CyclinD1存在互相抑制倾向,抑癌基因P16与癌基因CyclinD1可能协调参与调节胆管癌的发生发展。 [Objective]To investigate the relationship between the expression of P16 and Cyclin D1 proteins,and define the association of these proteins with clinicopathological characteristics,lymphatic metastasis of cholangiocarcinoma.[Methods]The expressions of P16 and Cyclin D1 protein were studied by streptoavidin-biotin complex.Paraffin sections from 45 cholangiocarcinomas and 10 normal(extrahepatic)bile duct specimens were examined.[Results]P16 expressed faintly in 100% of normal bile duct specimens,and no Cyclin D1 protein was detected in normal bile duct.The positive rates of P16 and Cyclin D1 in cholangiocarcinoma were 37.78%、66.67%respectively.The expression of P16 protein was significantly lower in cholangiocarcinoma than in normal bile ducts(P〈0.05).The expression of Cyclin D1 protein was significantly higher in cholangiocarcinoma than in normal bile duct.P16 expression was associated with clinical stage significantly(P=0.015),the positive rate of Cyclin D1 protein was associated with clinicopathological stage significantly(P=0.002),Between two proteins studied,expression of P16 and Cyclin D1 was inversely correlated(r=-0.374,P〈0.05).[Conclusion]Loss of P16 protein expression is a common event in the molecular oncogenesis and progression of extrahepatic bile duct carcinoma(EBDC)(P〈0.05).Cyclin D1 over expression is a common event in the molecular oncogenesis and progression of EBDC(P〈0.01).P16 protein expression is inversely correlated with Cyclin D1 expression.Loss of P16 protein expression and Cyclin D1 protein over expression act in cooperative ways to promote the molecular oncogenesis and progression of EBDC.
出处 《医学临床研究》 CAS 2007年第7期1133-1135,共3页 Journal of Clinical Research
关键词 胆管癌 基因 p16 细胞周期蛋白D1 cholangiocarcinoma genes,P16 cyclin D1
  • 相关文献

参考文献5

  • 1Tadatoshi Takayama,Masatoshi Makuuchi.Alterations of retinoblastoma protein and P16 protein Expression in extrahepatic bile duct carcinomas[J].Hepato-gastroenterology,2000,47:1216-1219.
  • 2Kanb A,Gruis NA,Weaver-Feldhans J,et al.Acen cycle regulater potentially involved in genesis of many tumor types[J].Science,1994 264:2336-2440.
  • 3Igaki H,Sasaki H.Mutation frequency of the P16/cdkn2 gene in primary cancer in the upper digestive tract[J].Cancer Res,1995,55(15):3421-3423.
  • 4谷化平,尚培中,周翠玲.胆管癌中PTEN和p16抑癌基因蛋白的表达及其临床意义[J].中国普通外科杂志,2004,13(2):101-103. 被引量:14
  • 5李谦平,杨鸿生.肺癌与p16和CyclinD1基因相关性研究进展[J].昆明医学院学报,2005,26(3):117-121. 被引量:1

二级参考文献31

  • 1朱如玮,刘振延.新型抑癌基因 p16[J].肿瘤,1997,17(3):178-179. 被引量:12
  • 2KAMB A, GRUIS N A, WEAVER - FELDHAUS J,et al. A cell cycle regulator potentially involved in genesis of many tumor types [J]. Science, 1994, 264(5157): 436.
  • 3MOTOKURA T, BLOOM T, KIM H G, et al. A novel cyclin encoded by a bcl1-linked candidate oncogene[J]. Nature, 1991, 350 (6318): 512.
  • 4WEINBERG R A. The retinoblastoma protein and cell cycle control[J]. Cell, 1995,81(3):323.
  • 5JIN X, NGUYEN D, ZHANG W W, et al. Cell cycle arrest and inhibition of tumor cell proliferation by the p16INK4 gene mediated by an adenovirus vector[J]. Cancer Res, 1995, 55(15): 3250.
  • 6WELCKER M, LUKAS J, STRAUSS M, et al. Enhanced protein stability: a novel mechanism of D-type cydin over - abundance identified in human sarcoma calls [J]. Oncogene, 1996, 13(2): 419.
  • 7ZHOU P, JIANG W, ZHANG Y J, et al. Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells[J]. Oncogene, 1995, 11(3): 571.
  • 8REED A L, CALIFANO J, CAIRNS P, et al. High frequency of p16 (CDKN2/MTS - 1/INK4A) inactivation in head and neck squamous cell carcinoma [J].Cancer Res, 1996, 56(16): 3630.
  • 9WASHIMI O, NAGATAKE M, OSADA H, et al.In vivo occurrence of p16 (MTS1) and p15 (MTS2)alterations preferentially in non - small cell lung cancers [J]. Cancer Res, 1995, 55(3): 514.
  • 10NAKAGAWA K, CONRAD N K, WILLIAMS J P,et al. Mechanism of inactivation of CDKN2 and MTS2 in non - small cell lung cancer and association with advanced stage [J]. Oncogene, 1995, 11(9):1843.

共引文献13

同被引文献34

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部